Search Results

Multiple sclerosis disease-modifying drugs: second line treatments

Most young people with Multiple sclerosis (MS), who are eligible for treatment, will be offered first line treatments. In certain situations, or if the first line treatments have not worked adequately, then your child may be offered the possibility of trying a second line medication. These medications, like the first line treatments, work by interacting with the immune system and calming the inflammation that is attacking the central nervous system.

Symbrachydactyly

Symbrachydactyly is a congenital (present at birth) hand anomaly, which affects a single upper limb. It is not inherited. It is characterised by short, stiff, webbed or missing fingers. The underlying muscles, tendons, ligaments and bones are all affected.